[Discovery of natural product-derived sequanamycins as potent oral anti-tuberculosis agents]

Med Sci (Paris). 2023 Aug-Sep;39(8-9):599-602. doi: 10.1051/medsci/2023091. Epub 2023 Sep 11.

[Article in French]

Authors

Sophie Lagrange¹, Christine Roubert¹, Jidong Zhang²

Affiliations

¹ Sanofi R&D, Infectious diseases unit, 31036 Toulouse, France - Evotec ID (LYON) SAS, Lyon, France.
² Sanofi R&D, Integrated drug discovery, Vitry-sur-Seine, France.

PMID: 37695145
DOI: 10.1051/medsci/2023091

No abstract available

Publication types

News

MeSH terms

Antitubercular Agents / therapeutic use
Biological Products*
Drug Discovery
Humans
Mycobacterium tuberculosis*

Substances

Antitubercular Agents
Biological Products